Article: FDA ISSUES ALERT ON ANTIHISTAMINE DRUG HISMANAL

Article: Sepracor Inc. Plans License Pact for Antihistamine ...
Knight Ridder/Tribune Business News;  February 9, 1998 ;     700+ words ... ... developed Allegra for Hoechst Marion Roussel. Allegra is the successor drug to Seldane, which the US Food and Drug Administration has taken off the market. In December, Sepracor signed a royalty agreement with Schering-Plough Corp., which ...

Article: PHARMACEUTICALS SEPRACOR IN LICENSE PACT FOR ANTIHISTAMINE ...
The Boston Globe;  February 8, 1998 ;     700+ words ... ... developed Allegra for Hoechst Marion Roussel. Allegra is the successor drug to Seldane, which the US Food and Drug Administration has taken off the market. In December, Sepracor signed a royalty agreement with Schering-Plough Corp., which ...

Article: Antihistamine drug wars: Claritin vs Zyrtec.
HealthFacts;  June 1, 1996 ;     700+ words ...Once again, fierce competition for doctor and consumer loyalty to a brand-name drug (not to mention almost $2 billion in U.S. sales) between drug manufacturers has spilled over into court. Although the lawsuits were settled before trial, the battle for the hearts and minds of 50 million allergy

Article: Hismanal should not be taken with certain other drugs. ...
FDA Consumer;  January 1, 1993 ;     700+ words ...People who take the non-sedating prescription antihistamine Hismanal (astemizole) should not take certain antifungal or antibiotic drugs at the same time because of the risk of life-threatening cardiac arrhythmias, commonly known as abnormal heart rhythms. This is the second non-sedating

Article: Caraco gets tentative OK for generic Zyrtec from FDA.(Caraco ...
Pharma Marketletter;  June 11, 2007 ;     673 words ... ... Caraco Pharmaceutical Laboratories says that the Food and Drug Administration has granted tentative approval its Abbreviated New Drug ... patent protection in December 25, 2007. Cetirizine is an antihistamine drug, which is used to treat allergies, hives, and other ...

Article: FDA ISSUES HISMANAL WARNING
PR Newswire;  July 20, 1992 ;     700+ words ... ... PRNewswire/ -- The Food and Drug Administration and Janssen Pharmaceutica, manufacturer of the prescription antihistamine drug Hismanal, today announced ... Monica Revelle of the Food and Drug Administration, 301-443-4177, or after ...

Article: Ex-production workers blew whistle on Copley. (Originated from ...
Knight Ridder/Tribune News Service;  September 15, 1994 ;     700+ words ... ... leading independent generic drug makers, failed to follow U.S. Food and Drug Administration-mandated manufacturing procedures in the production of an antihistamine drug, called Brompheril, according to two production workers who notified ...